Basel, Switzerland, November 20 (ots/PRNewswire) - - Authors Conclude Such Savings may Allow Healthcare Resources to be Reallocated to Other Aspects of Patient Management Switching dialysis patients to once-monthly Mircera(R) from older, more frequently dosed erythropoiesis stimulating agents (ESAs) could ...
Singapore, November 19 (ots/PRNewswire) - Further demonstrating its commitment to quality 3-D motion picture entertainment, The Walt Disney Studios has begun re-rendering its Oscar(R)-winning animated favorite, "Beauty and the Beast," in preparation for its Disney Digital 3-D(TM) debut on the big screen ...
Singapore, November 19 (ots/PRNewswire) - - Epic Fantasy From Director Robert Zemeckis and Starring Jim Carrey Leads Impressive Line-Up Disney's "A Christmas Carol," the spectacular 3D 2009 holiday release from director Robert Zemeckis and starring Jim Carrey, will be the first film from The Walt Disney Studios slated for IMAX(R) theatres under a new ...
Charlotte, North Carolina, November 17 (ots/PRNewswire) - Bank of America Corporation has given notice of its plan to exercise the remainder of its option to purchase ordinary shares of China Construction Bank Corporation from China SAFE Investments Limited (Huijin). Bank of America acquired the option from Huijin in connection with its investment in CCB in June ...
Rousset, France, November 17 (ots/PRNewswire) - - AT91SAM9G20 Joins Entire AT91SAM9 Family on Linux v2.6.27 Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the latest Linux(R) mainline release, v2.6.27, for its 400 MHz ARM926EJ-S(TM)-based AT91SAM9G20 embedded microprocessor, and for other members of the AT91SAM9 family. The short ...
London, November 17 (ots/PRNewswire) - - Results of Major AMD European Survey Into Notebook Usage, Content and Connectivity Across Europe, we are transforming into a continent of content-craving 'connect-aholics', according to the findings of the AMD European Connectivity Study of over 5,000 online respondents. Sponsored by AMD (NYSE: AMD), in conjunction ...
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has ...
Basel, Switzerland, November 13 (ots/PRNewswire) - - Phase III Trial Shows Patients With Advanced Adenocarcinoma of the Lung Have a 45% Better Chance of Survival With Avastin Roche announced today that an exploratory analysis of the pivotal phase III E4599 study demonstrated that Avastin (bevacizumab) ...
Rousset, France and Seoul, Korea, November 13 (ots/PRNewswire) - - Significant Performance Gains on Minimal Memory Footprint Atmel(R) Corporation (Nasdaq: ATML) and IBOSN Systems Co., Ltd. announced today the port of the JBOSN high-performance RTOS (real-time operating system) onto Atmel's AT91CAP9S customizable microcontroller. The JBOSN RTOS(TM) is a ...
Baar, Switzerland, November 13 (ots/PRNewswire) - - ZEVTERA(TM) A Broad-spectrum, Anti-MRSA Cephalosporin Antibiotic to Treat Complicated Skin and Soft Tissue Infections Approved in Switzerland - Not for UK Media Swissmedic, the Swiss agency for therapeutic products, has approved ZEVTERA(TM) (ceftobiprole medocaril) for the treatment of complicated skin ...
Paris, November 12 (ots/PRNewswire) - - Sanofi Pasteur and Chumakov Institute Russian Academy Medical Sciences Providers of Inactivated Polio Vaccine (IPV) IMOVAX PolioTM for Russia National "Project Health" Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that Russia has ...
Glasgow, Scotland, November 12 (ots/PRNewswire) - - Not Intended for Journalists in the UK or Ireland - New Findings From ARTEMIS and TITAN Studies Demonstrate Growth of the Tibotec Virology Franchise New data on PREZISTA(R) (darunavir), a protease inhibitor from Tibotec, will be presented at the Ninth International Congress on Drug Therapy in HIV ...
New Orleans, November 11 (ots/PRNewswire) - - Baseline Data from RecordAF Presented at American Heart Association's Scientific Sessions Today Baseline data from the REgistry on Cardiac rhythm disORDers - an international, observational, prospective survey assessing the control of Atrial Fibrillation ...
New Orleans, Louisiana, November 11 (ots/PRNewswire) - - New Post-Hoc Analysis From Athena Study Showed That Multaq(R) on Top of Standard Therapy Significantly Decreased the Total Number of Hospital Days by 28% in Patients With Atrial Fibrillation or Flutter NEW ORLEANS, Louisiana, November 11 /PRNewswire/ ...
Venice, Italy, November 11 (ots/PRNewswire) - Three winners and eight honourable mentions were presented and honoured at an Award event in Venice. Reilly O'Neil Hogan from the US won first prize. Chinese Ruan Hao and Xiong Xing won second prize, and Dean MacGregor from Portugal took third prize. (Photo: http://www.newscom.com/cgi-bin/prnh/20081111/327211-a ) ...
Birmingham, England, November 11 (ots/PRNewswire) - - Revenues Expected to be up 26%, Freelite(TM) Sales up More Than 50% The Binding Site Limited ("The Binding Site" or the "Company"), a privately-owned specialist UK diagnostics company, today announces a trading update for the year ended 30th September 2008. The full audited results will be announced in ...
Calgary, Canada, November 10 (ots/PRNewswire) - - First in Class Drug Illustrates Early Signal of Transport of Key Amyloid Marker From Brain - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from ...
London, November 10 (ots/PRNewswire) - - MrTedTalentLink(TM) Version 2.8 Provides Customers With Improved Forms, Flexibility and Technology to Attract, Recruit and Retain Top Talent MrTed, the leading global provider of Talent Acquisition Solutions, today announced the general availability of MrTedTalentLink(TM) latest version 2.8, its flagship ...
Basel, Switzerland, November 10 (ots/PRNewswire) - - Results Demonstrate Effective and Simplified Approach to Anaemia Management in Chronic Kidney Disease Patients on Dialysis Interim study results from 90 renal centres in Germany confirm for the first time that in a real-life setting Mircera(R) ...
Residual Risk Reduction Initiative (R3i)
New Orleans and Los Angeles, November 10 (ots/PRNewswire) - - Current Treatment Fails to Abolish Majority of Vascular Risk - Residual Risk Reduction Initiative (R3i) Calls for Action to Reduce the Lipid-Related Residual Vascular Risk Unaddressed by Current Standards of Care in Millions of Patients With ...
London, November 9 (ots/PRNewswire) - Platts -- The 13 members of the Organization of the Petroleum Exporting Countries (OPEC) pumped an average 32.26 million barrels per day (b/d) of crude oil in October, according to a Platts survey of OPEC and oil industry officials just released. This is a 210,000 b/d decline from the September level of 32.47 million b/d. ...
AstraZeneca Pharmaceuticals LP
New Orleans, November 9 (ots/PRNewswire) - New data from the JUPITER study demonstrated that CRESTOR(R) (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a ...
New York, November 7 (ots/PRNewswire) - - NRG CEO to Advocate Transition to Low Carbon-Emitting Society;Joins Former U.S. Secretary of State Albright as a Featured Speaker At the second annual Platts Lecture, "Sense and Sustainability: What Strategies Will Really Work to Create a New Energy Future?" NRG Energy President and CEO David Crane is expected to call on the energy industry to smooth its transition to a ...
Tokyo, November 7 (ots/PRNewswire) - - Large, International REACH Registry Also Shows Many Patients With Atrial Fibrillation are Undertreated With Antiplatelet and Anticoagulant Therapies A significant portion of patients with atherothrombosis also have atrial fibrillation (AF), greatly increasing their ...
Shenzhen, China, November 7 (ots/PRNewswire) - - Ultra low power AVR XMEGA - voted leading microprocessor Atmel(R) Corporation (Nasdaq: ATML), received a leading product accolade in the prestigious Electronic Design News (EDN) China Innovation Awards 2008. Atmel's highly successful AVR(R) picoPower(TM) 8/16-bit microcontroller, XMEGA(TM), won a leading product award in the Microprocessor and DSP category. ...
Residual Risk Reduction Initiative (R3i)
New Orleans, Louisiana, November 7 (ots/PRNewswire) - - Residual Vascular Risk Reduction: The Global Call to Action - Announcement of the Launch of the Residual Risk Reduction Initiative: R3i KEY FACTS: Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care ...
Burcon NutraScience Corporation
Vancouver, Canada, November 6 (ots/PRNewswire) - Burcon NutraScience Corporation (TSX-V: BU) announces today the appointment of BMO Capital Markets to act as exclusive financial advisor to Burcon in connection with a process to identify and pursue strategic alternatives for the commercialization of its innovative food technology. In engaging BMO Capital Markets, Burcon is initiating an extensive review of alternative strategies for maximizing shareholder value arising ...
Chicago, November 6 (ots/PRNewswire) - - Leveraging Leading Dynamic Distribution Capabilities from Traffic and Camera Alerts NAVTEQ, a leading global provider of digital map data for location-based solutions and vehicle navigation, today announced an exciting expansion to its dynamic content portfolio. Already a leading provider of camera alert data and real-time traffic to navigation systems, NAVTEQ now has ...
Ingelheim, Germany, November 5 (ots/PRNewswire) - - For Non-US Healthcare Media Can the quest for personalised medicine in cancer therapy ever be realised? And how far have we come in the journey to personalised cancer care? What lies ahead from a clinical research perspective will be discussed in an international media webcast entitled "Probable or pipedream: could new cancer targets change the outlook ...
Toronto, November 5 (ots/PRNewswire) - Trillium Therapeutics Inc., a privately held biopharmaceutical company, announced today that industry veterans Dr. Michael Berendt and Dr. John Dietrich have joined its Board as independent directors. Trillium Chairman Dr. Michael Moore commented: "It is a great pleasure to welcome these two experienced biotech executives to the Board where they will enhance our capabilities in ...